Markel Group’s Allergan plc AGN Stock Holding History
Bought
Maintained
Sold
Other funds holding AGN
BG
Markel Group's AGN Position: Q1 2018 in Review
Markel Group sold out of Allergan plc (AGN) in Q1 2018, closing a stake of 33,000 shares — an estimated $5.4M sold.
Markel Group first reported a position in AGN in Q3 2016 and held it in 6 quarters. The position peaked at $8.02M in Q2 2017. 1,022 funds tracked by Wall St. Rank hold AGN as of Q1 2018.
- Markel Group reported no remaining Allergan plc position as of Q1 2018 after selling out during the quarter.
- Markel Group sold 33,000 Allergan plc shares in Q1 2018, an estimated $5.4M.
- Markel Group first reported a position in Allergan plc in Q3 2016 and held it in 6 quarters.
- Markel Group's Allergan plc position peaked at $8.02M in Q2 2017.
- 1,022 funds tracked by Wall St. Rank held Allergan plc as of Q1 2018.
Based on Markel Group's 13F filing for Q1 2018, filed 27 Apr 2018.